Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/7615
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOmoboyowa, Damilola A.-
dc.contributor.authorAgoi, Mary D.-
dc.contributor.authorShodehinde, Sidiqat A.-
dc.contributor.authordkk.-
dc.date.accessioned2024-11-09T03:00:59Z-
dc.date.available2024-11-09T03:00:59Z-
dc.date.issued2023-
dc.identifier.issn1658-3612-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/7615-
dc.description.abstractObjective: The onset of insulin resistant diabetes has been associated with a high-sucrose diet in vertebrates and invertebrates. However, various parts of Spondias mombin reportedly possess antidiabetic potential. However, the antidiabetic efficacy of S. mombin stem bark in high-sucrose diet-induced Drosophila melanogaster model has not been explored. In this study, the antidiabetic and antioxidant effects of the solvent fractions of S. mombin stem bark were evaluated using in vitro, in vivo, and in silico methods. Methods: Successive fractionation of S. mombin stem bark ethanol extract was performed; the resulting fractions were subjected to in vitro antioxidant and antidiabetic assays using standard protocols. The active compounds identified from the high-performance liquid chromatography (HPLC) study of the n-butanol fraction were docked against the active site of Drosophila a-amylase using AutoDoc Vina. The n-butanol and ethyl acetate fractions of the plant were incorporated into the diet of diabetic and nondiabetic flies to study the in vivo antidiabetic and antioxidant properties. Results: The results obtained revealed that n-butanol and ethyl acetate fractions had the highest in vitro antioxidant capacity by inhibiting 2,2-diphenyl-1- picrylhydrazyl (DPPH), ferric reducing antioxidant power, and hydroxyl radical followed by significant inhibition of a-amylase. HPLC analysis revealed the identification of eight compounds with quercetin having the highest peak followed by rutin, rhamnetin, chlorogenic acid, zeinoxanthin, lutin, isoquercetin, and rutinose showing the lowest peak. The fractions restored the glucose and antioxidant imbalance in diabetic flies, which is comparable with the standard drug (metformin). The fractions were also able to upregulate the mRNA expression of insulin-like peptide 2, insulin receptor, and ecdysone-inducible gene 2 in diabetic flies. The in silico studies revealed the inhibitory potential of active compounds against a-amylase with isoquercetin, rhamnetin, rutin, quercetin, and chlorogenic acid having higher binding affinity than the standard drug (acarbose). Conclusion: Overall, the butanol and ethyl acetate fractions of S. mombin stem bark ameliorate type 2 diabetes in Drosophila. However, further studies are needed in other animal models to confirm the antidiabetes effect of the plant.en_US
dc.language.isoen_USen_US
dc.publisherJournal of Taibah University Medical Sciencesen_US
dc.relation.ispartofseriesOriginal Article;663-675-
dc.subjectAntioxidanten_US
dc.subjectDiabetesen_US
dc.subjectDrosophilaen_US
dc.subjectIn silicoen_US
dc.subjectIn vitroen_US
dc.subjectIn vivoen_US
dc.titleAntidiabetes study of Spondias mombin (Linn) stem bark fractions in high-sucrose diet-induced diabetes in Drosophila melanogasteren_US
dc.typeArticleen_US
Appears in Collections:Vol 18 No 4 (2023)

Files in This Item:
File Description SizeFormat 
663-675.pdf663-6753 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.